M. K. Proteins Limited (MKPL.BO)
INR 8.2
(-1.8%)
INR 8.2
(-1.8%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 314.71 Million | -76.96 Million | -101.22 Million | 55.35 Million | -44.68 Million | 63.51 Million |
| Net Income | 112.11 Million | 146.04 Million | 140.42 Million | 143.21 Million | 24.43 Million | 22.85 Million |
| Depreciation & Amortization | 5.28 Million | 7.57 Million | 9.13 Million | 9.09 Million | 11.71 Million | 12.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 192.1 Million | -182.33 Million | -208.94 Million | -82.35 Million | -72.5 Million | 40.22 Million |
| Other non-cash items | -98.57 Million | -48.25 Million | -41.83 Million | -14.59 Million | -8.32 Million | -11.79 Million |
| Investing Cash Flow | -58.88 Million | 133.84 Thousand | -15.27 Million | -2.11 Million | 1.75 Million | 2.69 Million |
| Investments in PPE | -59.24 Million | -72.05 Thousand | -15.72 Million | -2.59 Million | -318.5 Thousand | -1.59 Million |
| Acquisitions | - | 1.00 | 285.89 Thousand | - | 1.91 Million | 1.59 Million |
| Investment purchases | -29.5 Million | -45.5 Million | -202 Million | -36.5 Million | - | -50.29 Million |
| Sales/Maturities of investments | 29.86 Million | 45.59 Million | 202.49 Million | 36.91 Million | - | 50.6 Million |
| Other Investing Activities | 103 Thousand | 115.86 Thousand | -341.99 Thousand | 69.15 Thousand | 150.95 Thousand | 2.38 Million |
| Financing Cash Flow | -255.52 Million | 77.39 Million | 116.55 Million | -54.38 Million | 44.04 Million | -68.2 Million |
| Debt repayment | -254.32 Million | -1.04 Million | -51.04 Million | -41.11 Million | -11.33 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10.75 Million | 78.43 Million | 167.6 Million | -13.26 Million | 55.38 Million | - |
| Accounts receivables | 128.16 Million | 128.02 Million | -83.7 Million | -111.88 Million | 13.35 Million | - |
| Accounts payables | 66.86 Million | 2.43 Million | -29.71 Million | 25.61 Million | 31.49 Million | - |
| Inventory | -80.67 Million | -214.36 Million | -120.68 Million | 12.89 Million | -96.4 Million | 6.75 Million |
| Other working capital | 77.75 Million | -98.41 Million | 25.16 Million | -8.98 Million | -20.95 Million | 33.46 Million |
| Cash at beginning of period | 624.83 Thousand | 66.61 Thousand | 12.56 Thousand | 1.14 Million | 41.5 Thousand | 2.03 Million |
| Cash at end of period | 923 Thousand | 624.83 Thousand | 66.61 Thousand | 12.56 Thousand | 1.14 Million | 41.5 Thousand |
| Capital Expenditure | -59.24 Million | -72.05 Thousand | -15.72 Million | -2.59 Million | -318.5 Thousand | -1.59 Million |
| Effect of forex changes on cash | - | 0.30 | 0.39 | - | -0.18 | - |
| Net cash flow / Change in cash | 298.16 Thousand | 558.21 Thousand | 54.05 Thousand | -1.13 Million | 1.1 Million | -1.99 Million |
| Free Cash Flow | 255.46 Million | -77.03 Million | -116.94 Million | 52.76 Million | -45 Million | 61.92 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 112.11 Million | 24.79 Million | 4.12 Million | 24.9 Million | 146.04 Million | 140.42 Million |
| Depreciation & Amortization | 5.28 Million | 1.17 Million | 1.17 Million | 1.16 Million | 7.57 Million | 9.13 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 192.1 Million | - | - | - | -182.33 Million | -208.94 Million |
| Other non-cash items | -98.57 Million | -1.17 Million | -1.17 Million | -1.16 Million | -48.25 Million | -41.83 Million |
| Investing Cash Flow | -58.88 Million | - | - | - | 133.84 Thousand | -15.27 Million |
| Investments in PPE | -59.24 Million | - | - | - | -72.05 Thousand | -15.72 Million |
| Acquisitions | - | - | - | - | 1.00 | 285.89 Thousand |
| Investment purchases | -29.5 Million | - | - | - | -45.5 Million | -202 Million |
| Sales/Maturities of investments | 29.86 Million | - | - | - | 45.59 Million | 202.49 Million |
| Other Investing Activities | - | - | - | - | 115.86 Thousand | -341.99 Thousand |
| Financing Cash Flow | -255.52 Million | - | - | - | 77.39 Million | 116.55 Million |
| Debt repayment | -254.32 Million | - | - | - | -1.04 Million | -51.04 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 78.43 Million | 167.6 Million |
| Accounts receivables | 128.16 Million | - | - | - | 128.02 Million | -83.7 Million |
| Accounts payables | 66.86 Million | - | - | - | 2.43 Million | -29.71 Million |
| Inventory | -80.67 Million | - | - | - | -214.36 Million | -120.68 Million |
| Other working capital | 77.75 Million | - | - | - | -98.41 Million | 25.16 Million |
| Cash at beginning of period | 624.83 Thousand | 1.09 Million | -3.02 Million | - | 66.61 Thousand | 12.56 Thousand |
| Cash at end of period | 923 Thousand | 24.79 Million | 1.09 Million | 24.9 Million | 624.83 Thousand | 66.61 Thousand |
| Capital Expenditure | -59.24 Million | - | - | - | -72.05 Thousand | -15.72 Million |
| Effect of forex changes on cash | - | - | - | - | 0.30 | 0.39 |
| Net cash flow / Change in cash | 298.16 Thousand | 23.7 Million | 4.12 Million | 24.9 Million | 558.21 Thousand | 54.05 Thousand |
| Free Cash Flow | 255.46 Million | 24.79 Million | 4.12 Million | 24.9 Million | -77.03 Million | -116.94 Million |
ALBBY
OPXS
PCR
NBRFF
IMS
300632